Literature DB >> 28395108

B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2.

Daphne de Jong1, Margaretha G M Roemer1,2, John K C Chan3, John Goodlad4, Dita Gratzinger5, Amy Chadburn6, Elaine S Jaffe7, Jonathan Said8, Yasodha Natkunam5.   

Abstract

OBJECTIVES: The 2015 Workshop of the Society for Hematopathology/European Association for Haematopathology submitted small and large B-cell lymphomas (BCLs), including classical Hodgkin lymphoma (CHL), in the context of immunodeficiency.
METHODS: Clinicopathologic and molecular features were studied to explore unifying concepts in malignant B-cell proliferations across immunodeficiency settings.
RESULTS: Cases submitted to the workshop spanned small BCLs presenting as nodal or extranodal marginal zone lymphoma and lymphoplasmacytic lymphoma, Epstein-Barr virus (EBV) positive in 75% of cases. Submitted large BCLs formed a spectrum from diffuse large B-cell lymphoma (DLBCL) to CHL across immunodeficiency settings. Additional studies demonstrated overexpression of PD-L1 and molecular 9p24 alterations in the large BCL spectrum and across different immunodeficiency settings.
CONCLUSIONS: Small BCLs occur in all immunodeficiency settings, and EBV positivity is essential for their recognition as immunodeficiency related. Large BCLs include a spectrum from DLBCL to CHL across all immunodeficiency settings; immunohistochemical and molecular features are suggestive of shared pathogenetic mechanisms involving PD-L1 immune checkpoints. © American Society for Clinical Pathology, 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  9p24; Autoimmunity; Classical Hodgkin lymphoma; Iatrogenic immunodeficiency; Large B-cell lymphoma; Marginal zone lymphoma; PD-L1; Posttransplant lymphoproliferative disorder; Primary immunodeficiency; T-cell/histiocyte-rich B-cell lymphoma

Mesh：

Year:  2017        PMID： 28395108      PMCID： PMC6248547          DOI： 10.1093/ajcp/aqw216

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


  61 in total

1.  Synchronous biphenotypic Richter syndrome with Epstein-Barr virus-positive nodal classical Hodgkin lymphoma and bone marrow diffuse large B-cell lymphoma.

Authors:  Chan Y Cheah; Dominic Spagnolo; Felicity Frost; Gavin Cull
Journal:  Histopathology       Date:  2016-05-30       Impact factor: 5.087

2.  Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.

Authors:  D M Knowles; E Cesarman; A Chadburn; G Frizzera; J Chen; E A Rose; R E Michler
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

Review 3.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

4.  Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities.

Authors:  Miroslav Djokic; Michelle M Le Beau; Lode J Swinnen; Sonali M Smith; Charles M Rubin; John Anastasi; Katrin M Carlson
Journal:  Genes Chromosomes Cancer       Date:  2006-03       Impact factor: 5.006

5.  Lymphomas after solid organ transplantation: a collaborative transplant study report.

Authors:  Gerhard Opelz; Bernd Döhler
Journal:  Am J Transplant       Date:  2004-02       Impact factor: 8.086

6.  Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases.

Authors:  Eric Y Loo; L Jeffrey Medeiros; Tariq N Aladily; Daniela Hoehn; Rashmi Kanagal-Shamanna; Ken H Young; Pei Lin; Carlos E Bueso-Ramos; John T Manning; Keyur Patel; Vilmos Thomazy; Russell K Brynes; Maitrayee Goswami; Luis E Fayad; Roberto N Miranda
Journal:  Am J Surg Pathol       Date:  2013-08       Impact factor: 6.394

7.  Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.

Authors:  Wenbin Xiao; Wayne W Chen; Lynn Sorbara; Theresa Davies-Hill; Stefania Pittaluga; Mark Raffeld; Elaine S Jaffe
Journal:  Hum Pathol       Date:  2016-05-14       Impact factor: 3.466

8.  Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.

Authors:  Takashi Oyama; Kazuhito Yamamoto; Naoko Asano; Aya Oshiro; Ritsuro Suzuki; Yoshitoyo Kagami; Yasuo Morishima; Kengo Takeuchi; Toshiyuki Izumo; Shigeo Mori; Koichi Ohshima; Junji Suzumiya; Naoya Nakamura; Masafumi Abe; Koichi Ichimura; Yumiko Sato; Tadashi Yoshino; Tomoki Naoe; Yoshie Shimoyama; Yoshikazu Kamiya; Tomohiro Kinoshita; Shigeo Nakamura
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

9.  BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.

Authors:  E Cesarman; A Chadburn; Y F Liu; A Migliazza; R Dalla-Favera; D M Knowles
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

10.  Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.

Authors:  Takashi Oyama; Koichi Ichimura; Ritsuro Suzuki; Junji Suzumiya; Koichi Ohshima; Yasushi Yatabe; Takio Yokoi; Masaru Kojima; Yoshikazu Kamiya; Hirofumi Taji; Yoshitoyo Kagami; Michinori Ogura; Hidehiko Saito; Yasuo Morishima; Shigeo Nakamura
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394
View more
  13 in total

1.  Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies.

Authors:  Thomas Pincez; Julie Bruneau; Laureline Berteloot; Eve Piekarski; Caroline Thomas; Ambroise Marçais; Amélie Trinquand; Martin Castelle; Nicolas Garcelon; Dominique Plantaz; Morgane Cheminant; Despina Moshous; Thierry Jo Molina; Olivier Hermine; Elizabeth Macintyre; Alain Fischer; Stéphane Blanche; Felipe Suarez; Bénédicte Neven
Journal:  Haematologica       Date:  2019-12-26       Impact factor: 9.941

Review 2.  Emerging Concepts in Managing Malignancy in Kidney Transplant Patients.

Authors:  Brittany Schreiber; Maen Abdelrahim; Ala Abudayyeh; Naoka Murakami
Journal:  Semin Nephrol       Date:  2022-01       Impact factor: 4.472

Review 3.  Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Authors:  Yasodha Natkunam; Dita Gratzinger; Amy Chadburn; John R Goodlad; John K C Chan; Jonathan Said; Elaine S Jaffe; Daphne de Jong
Journal:  Blood       Date:  2018-08-06       Impact factor: 22.113

4.  T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4.

Authors:  Dita Gratzinger; Daphne de Jong; Elaine S Jaffe; Amy Chadburn; John K C Chan; John R Goodlad; Jonathan Said; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

5.  Epstein-Barr Virus-negative Marginal Zone Lymphoma as an Uncommon Form of Monomorphic Posttransplant Lymphoproliferative Disorder.

Authors:  Pallavi Galera; Richard Flavin; Natasha M Savage; Annapurna Saksena; Shunyou Gong; Huan-You Wang; Niall Swan; Liqiang Xi; Mark Raffeld; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2020-10       Impact factor: 6.298

6.  Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue.

Authors:  Bryan Rea; Yen-Chun Liu; Alanna Maguire; Lorinda A Soma; Chris M Bacon; Michael G Bayerl; Molly H Smith; Michael T Barrett; Steven H Swerdlow; Sarah E Gibson
Journal:  Mod Pathol       Date:  2021-12-24       Impact factor: 8.209

Review 7.  Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group.

Authors:  Simon Bomken; Jutte van der Werff Ten Bosch; Andishe Attarbaschi; Chris M Bacon; Arndt Borkhardt; Kaan Boztug; Ute Fischer; Fabian Hauck; Roland P Kuiper; Tim Lammens; Jan Loeffen; Bénédicte Neven; Qiang Pan-Hammarström; Isabella Quinti; Markus G Seidel; Klaus Warnatz; Claudia Wehr; Arjan C Lankester; Andrew R Gennery
Journal:  Front Immunol       Date:  2018-12-12       Impact factor: 7.561

8.  3D image analysis reveals differences of CD30 positive cells and network formation in reactive and malignant human lymphoid tissue (classical Hodgkin Lymphoma).

Authors:  Julia Liebers; Patrick Wurzel; Kerstin Bianca Reisinger; Martin-Leo Hansmann
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

9.  Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment.

Authors:  Mathis Overkamp; Massimo Granai; Irina Bonzheim; Julia Steinhilber; Jens Schittenhelm; Wolfgang Bethge; Leticia Quintanilla-Martinez; Falko Fend; Birgit Federmann
Journal:  Virchows Arch       Date:  2020-12-15       Impact factor: 4.064

10.  Cutaneous plasmacytoma-like posttransplant lymphoproliferative disorder after renal transplantation with response to imiquimod 5% cream and reduced immunosuppression.

Authors:  Danya Traboulsi; John Wink; Rachel Wong; Iwona Auer; Pavandeep Gill; Jason Tay; Jori Hardin
Journal:  JAAD Case Rep       Date:  2019-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.